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NeuronHyperglycemia in patients with type 2 diabetes causes multiple neuronal complications, e.g., diabetic
polyneuropathy, cognitive decline, and embryonic neural crest defects due to increased apoptosis. Possible
mechanisms of neuronal response to increased glucose burden are still a matter of debate. Insulin and insulin-
like growth factor-1 (IGF-1) receptor signaling inhibits glucose-induced caspase-3 activation and apoptotic
cell death. The insulin receptor substrates (IRS) are intracellular adapter proteins mediating insulin's and IGF-
1's intracellular effects. Even though all IRS proteins have similar function and structure, recent data suggest
different actions of IRS-1 and IRS-2 in mediating their anti-apoptotic effects in glucose neurotoxicity. We
therefore investigated the role of IRS-1/-2 in glucose-induced caspase-3 activation using human
neuroblastoma cells. Overexpression of IRS-1 or IRS-2 caused complete resistance to glucose-induced
caspase-3 cleavage. Inhibition of PI3-kinase reversed this protective effect of IRS-1 or IRS-2. However, MAP-
kinases inhibition had only minor impact. IRS overexpression increased MnSOD abundance as well as BAD
phosphorylation while Bim and BAX levels remained unchanged. Since Akt promotes cell survival at least
partially via phosphorylation and inhibition of downstream forkhead box-O (FoxO) transcription factors, we
generated neuroblastoma cells stably overexpressing a dominant negative mutant of FoxO1 mimicking
activation of the insulin/IGF-1 pathway on FoxO-mediated transcription. Using these cells we showed that
FoxO1 is not involved in neuronal protection mediated by increased IRS-1/-2 expression. Thus, over-
expression of both IRS-1 and IRS-2 induces complete resistance to glucose-induced caspase-3 activation via
PI3-kinase mediated BAD phosphorylation and MnSOD expression independent of FoxO1.ent of Internal Medicine II,
-Koch-Str. 21, 50931 Cologne,
97296.
Schubert).
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Hyperglycemia in type 2 diabetes causes an up to four-fold
increase of intracellular glucose concentration in neurons. If persistent
or frequently occurring, this glucose challenge leads to neuronal
damage often referred to as glucose neurotoxicity (review in [1]). The
pathological correlate of long term glucose neurotoxicity in patients
presents as diabetic neuropathy varying from mild paresthesia to
complete loss of sensibility. Diabetic neuropathy is the leading cause
for diabetic foot syndrome with ulcers, chronic non-healing lesions,
osteomyelitis and diabetic osteoarthropathy frequently resulting in
amputations. Investigation of different model organisms suggests that
hyperglycemia-induced caspase-3 activation is involved in the
pathogenesis of diabetic neuropathy even if the degree of caspase-3activation does not lead to lethal damage of dorsal root ganglia cells
[2–7]. Not less severely presents neuronal apoptosis induced by
hyperglycemia in pregnant women suffering from uncontrolled
diabetes leading to neural crest defects inducing embryonal death
or severe disability of the newborn child [8].
Most authors so far favor oxidative stress as molecular mechanism
for glucose neurotoxicity, which is promoted by glucose through a
combination of increased free-radical production and impaired free-
radical clearance. In case of hyperglycemia glucose is not only
metabolized via glycolysis but also via the polyol pathway affecting
the glutathione cycle by exhausting NADPH [9,10]. This decreases the
capacity of glutathione peroxidase to metabolize hydrogen peroxide
[11].
Insulin receptor (IR) and insulin-like growth factor (IGF)-1 receptor
(IGF-1R) signaling has been shown to inhibit glucose-induced caspase-3
activation and neuronal apoptosis [12]. IR and IGF-1R transmit their
intracellular signaling via so called insulin receptor substrates (IRS). The
mammalian IRS protein family has at least four members, IRS-1 to IRS-4,
which are characterized by an N-terminal pleckstrin homology (PH)
domain, aphosphotyrosine-binding (PTB)domain aswell as aC-terminal
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IRS-1, IRS-2, and IRS-4are expressed inmice aswell as inhumans, IRS-3 is
exclusively found in rodent adipose tissue [14]. Upon activation the IRS
proteins bind several SH2 domain-containing signaling proteins, such as
the regulatory subunit of phosphatidylinositol-3-kinase (PI3K), growth
factor receptor binding protein (GRB)-2, and SH2-phosphatase (SHP)-2.
Activation of PI3K results in phosphorylation of PtdIns (phosphatidyli-
nositols) to generate PtdIns-triphosphate (PtdIns-3,4,5-P). This leads to
an activation of several downstream targets, such as phosphoinositide-
dependent protein kinase (PDK)-1/-2, protein kinase B (PKB, also known
as Akt), and inhibition of glycogen synthase kinase-3β (GSK-3β).
Furthermore, Akt phosphorylates the forkhead transcription factor
FoxO1, which triggers its nuclear exclusion and thereby regulates
transcription [15,16].
Activation of the PI3K/Akt cascade promotes neuronal growth and
survival by phosphorylating FoxO-transcription factors to regulate
gene transcription (e.g., FAS ligand) and phosphorylating Bcl-2-
associated death promoter/anti-Bcl-2 antagonist of cell death (BAD)
protein [17–19]. Furthermore, IGF-1 suppresses Bim expression via
the PI3K and the MAP-kinase (MAPK) pathways to inhibit apoptosis
[20]. Akt also inactivates GSK-3β, which promotes cellular metabo-
lism, proliferation, and survival [21].
So far the only study dealing with the role of IRS proteins in
mediating the antiapoptotic effect of insulin and IGF-1 in the context
of glucose neurotoxicity suggests that IRS-2 but not IRS-1 mediates
insulin's and IGF-1's antiapoptotic effects [22].
In order to further dissect the role of IRS-1 and IRS-2 as mediators
of neuronal response to glucose challenge we generated human
neuroblastoma cells overexpressing either IRS-1 or IRS-2. Here we
show that IRS-1 and IRS-2 overexpression induces resistance to
glucose-induced caspase-3 activation via PI3K mediated BAD phos-
phorylation and increased MnSOD expression independent of FoxO1.
2. Materials and methods
2.1. Generation of stable cell lines
IRS-1 was ampliﬁed from cDNA using the following primers: 5′-
AAGTCGACGAATTCGCATGGCGAGCCCTCCGGAGAGCGAT-3′ and 5′-
GATCTA GAAAGCTTCTACTGACGGTCCTCTGGCTGCTTCTG-3′. The PCR
fragment was cloned into the eukaryotic expression vector pCMV-Tag
2C (Stratagene) using EcoRI and HindIII. IRS2 was ampliﬁed using 5′-
CGGGATCCTGATGGCTAGCGCGCC-3′ and 5′-GGAATTCTCACTCTTTCAC-
GACTG-3′ as primers. The ﬁnal product was ligated BamHI/EcoRI into
pCMV-Tag 2C. Foxo-DN was cloned using 5′-AAAGGATC CGCCAC-
CATGGCCGAAGCGCCCCAGGTGGT-3′ as forward and 5′-AAACTCGAG
GTCCATGGACGCAGCTCTTCTCCG-3′ as reverse primer. Final product
was ligatedXhoI/BamHI into pCMV-Tag2C for eukaryotic expression.As
a control cell line, we transfected SHSY5Y cells with the pCMV-Tag 2C
vector without insert (empty vector; EV). To achieve stable transfection
of SHSY5Y neuroblastoma cells, constructs were linearized before with
MluI (Fermentas). All cells were transfected using Effectene (Qiagen)
according to the manufacturer's instructions. Selection of successfully
transfected cellswas started after 72 h usingDMEMwith 1 mg/ml G418
(Sigma). After 1 week of selection single clones were picked and
transferred into 96-well plates (Greiner-bio-one) using DMEM with
1 mg/ml G418. Afterwards, cells were harvested and tested for IRS-1,
IRS-2 and FoxODN protein expression by Western blot, respectively. In
case of siRNA expression, pSuppressorNeo vector system containing the
appropriate siRNA [23] was used.
2.2. Cell culture
SHSY5Y cells were maintained in DMEM (Gibco) containing
GlutaMAX-I, 4.5 g/l D-glucose (or as indicated for the particular
experiment) and sodium pyruvate, supplemented with 10% FCS andwere grown at 37 ° C with 5% CO2. Glucose (Roth) or mannitol (Sigma)
in ﬁnal concentrations of 10, 100 and 250 mM were used in the
described experiments. For stimulation with IGF-1 (Sigma) or insulin
(Sigma) we used ﬁnal concentrations of 1, 10 and 100 nM, respectively.
50 μM PD98,059 (Sigma) was used for MEK pathway and 20 μM
LY294002 (Calbiochem) for PI3-kinase inhibition. Since both inhibitors
are dissolved in DMSO (Sigma), we treated control cells with the same
volume of DMSO without inhibitors to exclude solvent effects.
2.3. Immunoblotting
Cells were lysed in cell lysis buffer [10 mM Tris–HCl (pH 7.4)], 1%
Triton X-100, 10 mM EDTA, 50 mM NaCl, 50 mM NaF, 2 mM NaVO3,
1 mM PMSF and 0,1 μg/ml aprotinine). After addition of Laemmli
buffer, boiling samples were separated on 10% or 15% SDS–PAGE.
Proteins were transferred to PVDF membranes and unspeciﬁc binding
sites were blocked afterwards with 10% Western blot blocking
solution (Roche). The following primary antibodies were used: anti-
protein kinase B (Akt), anti-Bax protein, anti-Bim protein, anti-
caspase-3, anti extracellular regulated kinase (ERK)-1/2, anti-phos-
pho-ERK-1/2Thr202/Thr204, anti-glycogen synthase kinase (GSK)-3, anti
phospho-GSK-3Ser9, anti-insulin like growth factor (IGF-1) receptor,
anti-insulin receptor β subunit (IRβ) (all Cell Signaling), anti-insulin
receptor substrate 1 (IRS-1), anti-insulin receptor substrate 2 (IRS-2)
(both Upstate), anti-actin (MP Biomedicals), anti-Bcl-2 antagonist of
cell death (BAD), anti-pospho-BADSer136, anti-glucose transporter
type 3 (GLUT3), anti superoxide dismutase 1 (SOD-1, Cu/ZnSOD)
(Santa Cruz), anti-superoxide dismutase 2 (SOD-2, MnSOD) (Up-
state), anti RasGAPwas a kind gift fromDr. S. Rosenkranz, Department
of Internal Medicine III, University of Cologne. For quantiﬁcation of
optical density AIDA 4.00.027 software (Raytest, Straubenhardt,
Germany) was used. For statistical analysis unpaired Student's t-test
was performed. Statistical signiﬁcance was deﬁned as Pb0.05.
2.4. Immunoprecipitation
Immunoprecipitation was performed by incubating 1 mg protein
lysate overnight at 4 °C on an overhead shaker using anti-FLAG-M2-
antibody coupled agarose beads (Sigma). Samples were washed three
times with PBS, resuspended in 4× SDS sample buffer (250 mM Tris–
HCl (pH 6.8), 200 mM DTT, 8% SDS, 0.04% bromphenol-blue, 40%
glycerol) and analyzed by Western blotting using anti-IRS-1 or anti-
IRS-2 for detection.
2.5. Real time PCR
For real time PCR, we isolated RNA from cells using RNeasy Mini Kit
(Qiagen). cDNA synthesis was performed with the SuperScript VILO
cDNA synthesis kit (Invitrogen) according to the manufacturer's
instructions. TodeterminemRNA levels, a TaqManassaywas performed
on a Step One Plus real time PCR system (Applied Biosystems) using
IRS-1 (Hs00178563_m1) and IRS2 (Hs00275843_s1) asprobes (Applied
Biosystems). For endogenous control we used an 18 s eukaryotic rRNA
(4319413E) probe. Relative gene expression was quantiﬁed using the
ΔΔCt method.
3. Results
3.1. Generation of IRS-1 and IRS-2 overexpressing human neuroblastoma
cell lines
For generation of cell lines stably overexpressing IRS-1 or IRS-2,
neuroblastoma cells (SHSY5Y) were used. The cDNA coding for either
IRS-1 or IRS-2 was cloned into pCMV-Tag 2C. Linearized vector was
transfected using Effectene (Qiagen) according to the manufacturer's
instructions. As controls, SHSY5Y cells were transfected with the empty
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with selection medium containing 1 mg/ml G418 (Sigma). After
3 weeks of selection, single cells were separated on 96-well plates.
Clones which were grown from these single cells were tested for
expression of the particular IRS-gene, and positive clones were selected
for further experiments. The cells used for experiments were grown
without G418. In order to visualize successful transfection of full length
cDNA of either IRS-1 or IRS-2 we used the T3-, T7-primers for PCR
(Supplementary Fig. 1). PCR with these primers revealed the expected
PCR-product size for FLAG-IRS-1, FLAG-IRS-2, and EV. RT-PCR of IRS-1
and IRS-2 showed an approximately 1.7-fold increase of IRS-1 mRNA in
IRS-1 overexpressing cells with unchanged IRS-2 mRNA expression
compared to EV and untransfected SHSY5Y cells (Fig. 1A and B).
mRNA of IRS-2 was approximately 1.5-fold higher in FLAG-IRS-2
overexpressing cells compared to EV and SHSY5Y cells (Fig. 1B). IRS-1
mRNA concentrations did not change in IRS-2 overexpressing cells
(Fig. 1A and B). Immunoprecipitation using anti-FLAG-antibody-
coupled agarose beads revealed remarkable expression of FLAG-IRS-1
and FLAG-IRS-2 in the accordingly transfected cells (Fig. 1C). WesternFig. 1. Characterization of IRS-1 and IRS-2 overexpressing cells. A) Real-time PCR using
TaqManprobes for IRS-1 inuntransfectedSHSY5Y(SY), EV (empty vector), IRS-1 and IRS-2
overexpressing cells. Results are expressed as fold increase compared to untransfected
SHSY5Y representing 3 independent experiments. B) Real-time PCR using TaqMan probes
for IRS-2 in untransfected SHSY5Y, EV, IRS-1 and IRS-2 overexpressing cells. Results are
expressed as fold increase compared tountransfected SHSY5Y representing3 independent
experiments. C) Immunoprecipitation using anti-FLAG-antibody coupled agarose beads
followed by SDS–PAGE andWestern blot for IRS-1 and IRS-2. Each lane labeled with IRS-1
or IRS-2 represents a separate clone of IRS-1 and IRS-2 overexpressingcells.D) IRS-1 and -2
Western blot from cell lysates of IRS-1 or IRS-2 overexpressing, EV and untransfected
SHSY5Ycells. E)Westernblots for pAktSer473, Akt, Erk-1/-2,pErk-1/-2Thr202/Thr204, actin and
GLUT3 from cell lysates of untransfected SHSY5Y, EV, IRS-1 and IRS-2 overexpressing cells.
Each lane labeled with IRS-1 or IRS-2 represents a separate clone of IRS-1 and IRS-2
overexpressing cells.blots for IRS-1 and IRS-2 showed indeed that FLAG-IRS-2overexpressing
cells largely overexpress IRS-2 without changes in IRS-1-expression
(Fig. 1D). In turn, IRS-1was far overexpressed in FLAG-IRS-1 expressing
cells, again without any changes of IRS-2-expression (Fig. 1D). The
experiments proved successful generation of IRS-1 and IRS-2 over-
expressing cells. Three different clones of either IRS-1 or IRS-2
overexpressing cells were selected for further experiments. All experi-
ments reported here were repeated at least in two different clones of
IRS-1 and IRS-2 overexpressing cells.
Since we aimed to study the effect of IRS-1/-2 overexpression on
glucose-induced stress we measured expression of glucose transport-
er 3 (GLUT3), the most important glucose transporter in neurons.
Western blots using GLUT3 speciﬁc antibodies revealed no changes in
GLUT3 expression between the different clones as well as between
IRS-1, IRS-2, EV and untransfected SHSY5Y cells (Fig. 1E) excluding
artifacts due to altered glucose transport between the different cell
lines.
3.2. IR/IGF-1R signaling is increased in IRS-1 and IRS-2 overexpressing
cells
To investigate downstream signaling, we used 3 different clones of
IRS-1 and IRS-2 overexpressing cells and measured expression and
phosphorylation of important kinases of the IR/IGF-1R signaling
cascade. We found no changes in Akt and Erk-1/-2 expression in our
cell lines without any difference between the three individual clones
per group or between IRS-1 and IRS-2-overexpressing cells (Fig. 1E).
Furthermore, we did not ﬁnd any changes of GSK-3β, IR, and IGF-1R
expression under conditions of IRS-1 or IRS-2 overexpression
compared to EV and untransfected SHSY5Y cells and between IRS-1
and IRS-2 cells (data not shown). Basal phosphorylation of AktSer473,
Erk-1Thr202 and Erk-2Thr204 was increased in all three clones of IRS-1
and IRS-2 overexpressing cells compared to EV and untransfected
SHSY5Y cells (Fig. 1E) without any difference between IRS-1 and IRS-2
overexpressing cells, suggesting that IRS-1 and IRS-2 mediate
downstream signaling to a similar extent.
In order to study IRS signaling in the different cell lines after IGF-
1 stimulation we treated the different cells with 0, 1, 10, 100 nM IGF-
1 ﬁnal concentrations for 5 min and used AktSer473, Erk-1Thr202 and
Erk-2Thr204 phosphorylation as readout for activation of the IGF-1R
signaling cascade. As expected, all cell lines respond to IGF-1
stimulation with an increase in AktSer473 and Erk-1/-2Thr202/Thr204
phosphorylation. IRS-1 and IRS-2 overexpressing cells showed
higher basal and IGF-1 stimulated phosphorylation of AktSer473 and
Erk-1/-2Thr202/Thr204 compared to EV and untransfected SHSY5Y cells
without any difference between IRS-1 and IRS-2 overexpressing
cells, suggesting that IRS-1 and IRS-2 both are capable of mediating
IGF-1's intracellular effects (Fig. 2). Similar experiments using insulin
treatment (0–100 nM ﬁnal concentration, 5 min stimulation) revealed
analog results (data not shown).
To analyze variation in the expression of Erk and Akt in the cell
lines we quantiﬁed expression of these proteins in our signaling
experiments using actin expression as loading control (Supplemen-
tary Fig. 2). These experiments exclude changes in Erk/Akt protein
expression inﬂuencing the quantiﬁcation of phospho/total Erk and
Akt ratios.
3.3. Glucose challenge does not alter IGF-1-induced Akt phosphorylation
Recent data suggest a distinct role of IRS-1 and IRS-2 to inhibit
glucose-induced caspase-3 activation [22]. According to these data,
IRS-1 undergoes rapid caspase-mediated degradation in the presence
of high glucose levels. However, hyperglycemia-mediated IRS-2
degradation occurs slowly and is blocked by proteasome and calpain
inhibitors possibly explaining why IRS-2, but not IRS-1 rescues
glucose-induced caspase-3 activation and apoptosis in this study
Fig. 2. IGF-1 signaling is increased in IRS-1 and IRS-2 overexpressing cells. Cells of the different cell lines were cultured in DMEM and 10% FCS to 80% conﬂuence. Prior to IGF-1
stimulation cells were serum starved overnight. For IGF-1 treatment 0, 1, 10, 100 nM IGF-1 were applied for 5 min. After IGF-1 stimulation cells were lysed and SDS–PAGE and
Western blots were performed as described in Materials and methods. Antibodies against pAktSer473, Akt, Erk-1/-2 and pErk-1/-2Thr202/204 were used. To quantify changes in optical
density, we used the software AIDA 4.00.027 (Raytest, Straubenhardt, Germany). Results were expressed as fold increase compared to untreated EV cells.
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IGF-1-induced Akt phosphorylation we treated serum starved cells
with glucose for 6 h, stimulated the cells with 10 nM IGF-1 for 5 min,
and performed Western blots to visualize Akt phosphorylation at
Ser473. Glucose treatment had no inﬂuence on basal Akt phosphor-
ylation in any cell type (Fig. 3). As expected, IGF-1-stimulated Akt
phosphorylation was increased in IRS-1 and IRS-2 overexpressing
cells compared to EV even under high glucose conditions (Fig. 3).
However, there were no differences in IGF-1-stimulated Akt phos-
phorylation in IRS-1 or IRS-2 overexpressing cells following 250 mM
glucose treatment excluding relevant IGF-1 resistance due to rapid
IRS-1 degradation in any cell type (Fig. 3, see also Fig. 7A).
3.4. IRS-1 and IRS-2 overexpression rescues glucose-induced caspase-3
activation
To investigate the role of IRS-1 and IRS-2 in the context of glucose-
induced caspase-3 activation we treated serum starved EV, untrans-
fected SHSY5Y, IRS-1 and IRS-2 overexpressing cells with 0, 10, 100,
and 250 mM glucose. In order to detect any inﬂuence of glucose-
unspeciﬁc osmotic artifacts we used mannitol-treated cells (0, 10,
100, 250 mM) as controls. As described previously, we found that
glucose treatment induced robust caspase-3 activation between 100
and 250 mM glucose in untransfected SHSY5Y cells (Fig. 4A and B)
[22]. Treatment with increasing doses of glucose in either IRS-1 or IRS-
2 overexpressing cells did not induce detectable caspase-3 cleavage,
suggesting that IRS-1 as well as IRS-2 overexpression rescues glucose
induced caspase-3 activation (Fig. 4C–F). Differences in caspase-3Fig. 3. Hyperglycemia does not cause IGF-1 resistance. EV, IRS-1 and IRS-2 over-
expressing cells were cultured in DMEM and 10% FCS to 80% conﬂuence, serum starved
for 4 h, treated with 0 or 250 mM glucose for 6 h. Glucose treated cells were
additionally stimulated with 0 or 10 nM IGF-1 for 5 min. Cells were lysed and SDS–
PAGE and Western blots were performed as described in Materials and methods. For
Western blots antibodies against pAktSer473 and Akt were used.cleavage between the IRS-1 or IRS-2 overexpressing cells or the
different clones of IRS protein overexpressing cells were not observed
(Fig. 4E and F). Thus, IRS-1 and IRS-2 overexpression rescues glucose
induced caspase-3 activation in SHSY5Y neuroblastoma cells similar-
ly. In most experiments, mannitol did not induce any detectable
caspase-3 cleavage. However, in some experiments we observed a
caspase-3 activation in mannitol treated cells independent of the cell
type used (for example Fig. 4C and D) suggesting that under certain
circumstances (glucose unspeciﬁc) osmotic stress might have an
inﬂuence even in concentrations about 100–250 mM.
To reinforce the role of IRS proteins in the context of glucose
neurotoxicity we used a siRNA approach to stably downregulate IRS-2
expression in SHSY5Y neuroblastoma cells, leading to about 75%
downregulation of IRS-2 (Supplementary Fig. 3). Surprisingly, we
observed an increased basal Akt activation in IRS-2 siRNA cells
compared to SHSY5Y cells at least partially due to compensation via
IRS-1 expression especially under conditions of serum starvation.
Because of this compensatory mechanism our knockdown approach
was not helpful to distinguish between the function of the different
IRS proteins at least in SHSY5Y neuroblastoma cells.
3.5. IRS protein-mediated inhibition of caspase-3 activation is PI3K
dependent
As suggested by previous studies, we tested whether IGF-1 is
capable to inhibit glucose-induced caspase-3 activation. Therefore, we
treated serum starved EV cells with 250 mM glucose for 6 h with and
without 10 nM IGF-1 stimulation. IGF-1 treatment completely
blocked glucose-induced caspase-3 cleavage, reinforcing the impor-
tance of IGF-1 signaling in this context (Fig. 5A). To elucidate the role
of the different IRS-activated signaling pathway proteins possibly
mediating the inhibition of glucose-induced caspase-3 activation we
used inhibitors of the PI3K (LY294002) and MAPK pathway (MEK-1
inhibitor: PD98,059). As shown in our previous experiments, glucose
treatment of EV cells caused robust caspase-3 activation (Fig. 5B).
Neither LY294002 (20 μM ﬁnal concentration) nor PD98,059 (50 μM
ﬁnal concentration) treatment had any effect on glucose-induced
caspase-3 cleavage in EV cells, suggesting that under basal conditions
PI3K and MAPK do not inhibit caspase-3 activation (Fig. 5B). As
described above, IRS-1 and IRS-2 overexpressing cells are, even under
basal conditions (serum starved, no IGF-1 treatment), completely
protected against glucose-induced caspase-3 activation (Fig. 5C
Fig. 4. Glucose-induced caspase-3 cleavage in IRS-1 and IRS-2 overexpressing cells. Untransfected SHSY5Y (A, E), EV (B, E), IRS-1 and IRS-2 overexpressing (C, D, E) cells were
cultured in DMEM and 10% FCS to 80% conﬂuence. Four-hour serum starved cells were treated with 0, 10, 100, 250 mM glucose or mannitol for 6 h. Cells were lysed and SDS–PAGE
and Western blots were performed as described in Materials and methods. For Western blots, antibodies against full length and cleaved caspase-3 forms as well as actin were used.
Blots represent typical results of at least 3 independent experiments in 3 different clones of IRS-1 and IRS-2 overexpressing cells. To quantify the changes in optical density, we used
the software AIDA 4.00.027 (Raytest, Straubenhardt, Germany). Results were expressed as fold increase compared to EV cells. *p≤0.05 unpaired Student's t-test.
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effect of IRS-1 and IRS-2 overexpression. However, it should be noted
that the MEK1 inhibitor PD98,059 had a minor but still reproducibleFig. 5. Mainly PI3K mediates inhibition of glucose induced caspase-3 activation in IRS-1 an
conﬂuence. Four-hour serum starved cells were treated with 0 or 250 mM glucose for 6 h. P
Cells were lysed and SDS–PAGE and Western blots were performed as described in Mater
pAktSer473 and Akt were used as primary antibodies. EV (B), IRS-1 and IRS-2 overexpressing c
incubated with or without 250 mM glucose for 6 h. Glucose treated cells were additionally in
Western blots were performed as described in Materials and methods. For Western blots,
represent typical results of a least 2 independent experiments.effect (Fig. 5C and D). Taken together, in case of glucose neurotoxicity
IRS-proteins mediate their protective effect mainly via the PI3K
pathway.d IRS-2 overexpressing cells. A) EV cells were cultured in DMEM and 10% FCS to 80%
rior to glucose treatment cells were stimulated with IGF-1 (10 nM ﬁnal concentration).
ials and methods. Antibodies against RasGAP, caspase-3 and cleaved caspase-3 forms,
ells (C, D) were cultured in DMEM and 10% FCS to 80% conﬂuence, serum starved for 4 h,
cubated with 20 μM LY294002 or 50 μM PD98,059. Cells were lysed and SDS–PAGE and
antibodies against RasGAP, caspase-3 and cleaved caspase-3 forms were used. Figures
578 O. Stöhr et al. / Biochimica et Biophysica Acta 1812 (2011) 573–5803.6. Bim expression is not responsible for IRS-1 or IRS-2 mediated effects
on glucose neurotoxicity
One mechanism how IGF-1 mediates its anti-apoptotic effects is the
rapid regulation of the pro-apoptotic factor Bim. In other cell types it has
been reported that the PI3K and theMAPK pathway, activated by IGF-1,
suppress Bim expression via transcriptional, posttranslational and/or
epigenetic mechanisms [20]. We investigated Bim expression under
basal conditions and after treatment with MEK-1 and PI3K inhibitors.
Interestingly, there were no signiﬁcant differences in basal BimEL, BimL
and BimS expression between EV, IRS-1 or IRS-2 overexpressing cells
(Fig. 6A). PI3K inhibition increased BimEL, BimL and BimS expression in
all cell types similarly (Fig. 6A), excluding suppressed Bim expression as
molecular mechanism for the protective effect of IRS-1/-2. However, at
least in EV cells MEK-1 inhibition by PD98,059 had no inﬂuence on Bim
expression (Fig. 6A).3.7. BAD phosphorylation is increased due to IRS-1 and IRS-2
overexpression
Bcl-2-associated death promoter (BAD) protein is a pro-apoptotic
member of the Bcl-2 family. Unphosphorylated BAD forms hetero-
dimers with the anti-apoptotic factors Bcl-2 or Bcl-xL allowing BAX to
trigger apoptosis. It has been described that activation of the PI3K/Akt
cascade promotes survival by activation and phosphorylation of BAD
at Ser136 [17,18,24]. Upon phosphorylation, BAD binds 14-3-3 leaving
Bcl-2 free to inhibit BAX-triggered apoptosis. We therefore investi-
gated BAD expression and BADSer136 phosphorylation in our newly
generated cell lines. BAD concentrations were unaltered in all cell
types (Fig. 6B) without any difference between EV and untransfected
SHSY5Y as well as between the three different clones of IRS-1 and
IRS-2 overexpressing cells used in the present study. Interestingly,
IRS-1 and IRS-2 overexpressing cells showed remarkably increased
basal BAD phosphorylation at Ser136 (Fig. 6B) in all three different
clones of each cell type compared to EV and untransfected SHSY5Y
cells suggesting that elevated BAD phosphorylation is one of the
mechanisms how IRS-proteins mediate the inhibition of caspase-3
cleavage (Fig. 6B). However, BAX expression was unaltered in IRS-1-
and IRS-2 overexpressing cells compared to EV and untransfected
SHSY5Y cells. Thus, increased BAD phosphorylation might preventFig. 6. BAD, Bim, BAX expression and BAD phosphorylation in IRS-1 and IRS-2
overexpressing cells. A) EV, IRS-1 and IRS-2 overexpressing cells were cultured in
DMEM and 10% FCS to 80% conﬂuence, serum starved for 4 h, treated with 0 or 250 mM
glucose for 6 h. Glucose treated cells were additionally incubated with 20 μM LY294002
or 50 μM PD98,059 prior to glucose addition. Antibodies detecting BimEL, BimL and
BimS were used for Western blots. B) EV, IRS-1 and IRS-2 overexpressing cells were
cultured in DMEM and 10% FCS to 80% conﬂuence. Cells were lysed. SDS–PAGE and
Western blots were performed as described in Materials and methods. Primary
antibodies against pBADSer136, BAD, BAX and actin were used.glucose-induced caspase-3 activation in IRS-1 and IRS-2 overexpres-
sing cells.
3.8. MnSOD expression is increased in IRS-1/-2 overexpressing human
neuroblastoma cells
Several defense mechanisms to oxidative stress have been
described, reaching from expression of SODs (superoxide dismutases)
to activation of the glutathione cycle. In aortic endothelial cells high
glucose levels cause cell damage via increased ROS production.
Overexpression of the mitochondrial MnSOD nearly completely
prevents ROS generation suggesting that MnSOD might also be
involved in prevention of glucose neurotoxicity [9]. We therefore
investigated the expression of Cu/ZnSOD (SOD1) and MnSOD (SOD2)
under basal conditions and 250 mM glucose treatment for 6 h in EV
and IRS-protein overexpressing cells. Cu/ZnSOD expression was not
changed under basal conditions compared to 250 mM glucose
treatment in EV cells (Fig. 7A). Furthermore, the expression of Cu/
ZnSOD was similar in IRS-1 and IRS-2 overexpressing cells compared
to EV cells under basal conditions and glucose treatment (Fig. 7A). In
contrast, MnSOD expression was signiﬁcantly increased in IRS-1 and
IRS-2 overexpressing in comparison to EV cells (Fig. 7B) but did not
further increase or change in response to glucose challenge (Fig. 7A).
Thus, IRS-protein overexpression causes increased MnSOD levels
(Fig. 7B) independent of glucose treatment revealing a second
possible mechanism to defend cellular stress caused by increased
glucose burden.
3.9. FoxO is not involved in mediating the anti-apoptotic effect of
IRS-proteins in the context of glucose neurotoxicity
The mammalian forkhead box-O (FoxO) transcription factor family
contains at least 4members. FoxO1, FoxO3a and FoxO6 are expressed in
themammalianCNS. FoxO transcription factors are negatively regulated
by the IR/IGF-1R signaling cascade. Upon Akt activation, FoxOs get
phosphorylated and form heterodimers with 14-3-3 triggering their
nuclear export and degradation. In peripheral tissues, FoxO1 regulatedFig. 7. Increased MnSOD but not Cu/ZnSOD expression in IRS-1 and IRS-2 over-
expressing cells. A) EV, IRS-1 and IRS-2 overexpressing cells were cultured in DMEM
and 10% FCS to 80% conﬂuence, serum starved for 4 h, treated with 0 or 250 mMglucose
for 6 h. Glucose treated cells were additionally stimulated with 10 nM IGF-1 prior to
glucose addition. Western blots using antibodies against pAktSer473, MnSOD, Cu/ZnSOD,
and actin were performed as described inMaterials andmethods. B) EV, IRS-1 and IRS-2
overexpressing cells were cultured in DMEM and 10% FCS to 80% conﬂuence, lysed and
cell lysates were subject to SDS–PAGE and Western blots using antibodies against
MnSOD and actin as loading control. To quantify changes in optical density, we used the
software AIDA 4.00.027 (Raytest, Straubenhardt, Germany). Results were expressed as
fold increase compared to untreated EV cells. *p≤0.05 unpaired Student's t-test.
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oxidative stress (e.g., regulation of MnSOD expression).
In order to investigate the role of FoxO1 in this context we
generated a FoxO1 mutant missing the transactivation domain, and
therefore acting as dominant negative (DN), mimicking increased
insulin/IGF-1 signaling (Fig. 8A). This mutant was cloned into pCMV-
FLAG 2C and stably transfected into SHSY5Y, as described above.
Western blots using antibodies against FoxO1 proved FoxO1DN
expression (Fig. 8B). Two FoxO1DN expressing clones were used for
further experiments. We exposed FoxO1DN expressing cells to
250 mM glucose and mannitol for 6 h and performed Western blot
analysis to detect caspase-3 cleavage. However, there were no
differences in caspase-3 activation between DN expressing, EV and
untransfected SHSY5Y cells (Fig. 8B), suggesting that FoxO1 is not
involved in IRS-1/-2-mediated protection from high glucose
concentration.
4. Discussion
Insulin and IGF-1 strongly promote neuronal survival in response
to different stressors [25,26]. IGF-1 and insulin activate Akt to induce
BAD phosphorylation and its association with 14-3-3 to release and
activate Bcl-2 [19,24] and inhibit BAX-induced caspase-3 cleavage and
apoptosis.
It is not known whether different IRS-proteins exert differential
effects on cell survival. In 32D cells expressing IRs and either IRS-1, -2,
-3 or−4, Uchida and co-workers [27] showed that IR and IRS-1 or -2
expressing 32D cells mediate intracellular signaling and insulin's anti-
apoptotic effects equally. However, only IRS-4 seems to be less
effective [27]. Our group showed that the lack of either IRS-2 or IRS-1
did not reduce survival of cultured cerebellar granule cells. Further-
more, IGF-1 or BDNF prevented apoptosis in cerebellar granule cells
lacking IRS-1 or IRS-2. Thus, IRS-1 and IRS-2 might be exactly
redundant regarding IGF-1-mediated anti-apoptosis in neurons, or
other IGF-1-mediated signals might be involved [28].
Interestingly, recent data suggest that IRS-2, but not IRS-1
mediates inhibition of caspase-3 activation and apoptosis due to
high glucose levels in neuroblastoma cells. Furthermore, IRS-1
seemed to transmit IGF-1-induced Akt phosphorylation to less extent
compared to IRS-2, at least in certain neuronal cell lines, e.g. SH-EP
cells [22]. Even though IRS-1 and IRS-2 are almost similar in structureFig. 8. FoxO1 mediated transcription is not involved in the IRS-protein induced
protection against caspase-3 activation. A) Schematic drawing of the FoxO1DN mutant
which was cloned into pCMV-Tag 2C vector and stably transfected in SHSY5Y cells as
described in Materials and methods. B) Untransfected SHSY5Y, EV, and FoxO1DN cells
were cultured in DMEM and 10% FCS to 80% conﬂuence, serum starved for 4 h, treated
with 0 or 250 mM glucose for 6 h. Western blots using antibodies against actin, FoxO1
and cleaved caspase-3 were performed. The two lanes labeled DN represent two
different clones of FoxO1DN expressing cells. Figure represents typical results of 2
independent experiments. NLS: nuclear localization signal, NES: nuclear export signal,
FKH: forkhead domain.and function [29] the phenotypes of the according knockout mice are
rather different [30–32], suggesting that the abundance of the
different IRS-proteins might play a critical role in mediating the
intracellular effects of insulin and IGF-1 [33,34]. Therefore, it has been
argued that differential degradation of IRS-1 and IRS-2 due to high
glucose levels largely contributes to their distinct role in mediation of
the anti-apoptotic response to glucose challenge in neurons [22].
Although we could reproduce the previously described data on
degradation of IRS-2 and IRS-1 after glucose treatment (data not
shown), 10 nM IGF-1 still induced Akt phosphorylation in EV as well
as in IRS-1 and IRS-2 overexpressing cells, suggesting that glucose
treatment does not cause signiﬁcant IGF-1 resistance in SHSY5Y cells,
and that degradation of the different IRS-proteins is of minor
importance in this context. Even an approximately 75% siRNA-
mediated knockdown of IRS-2 in SHSY5Y cells which transmit IGF-
1s intracellular signaling mainly via IRS-2 does not reduce but
increase Akt phosphorylation. Our data suggest that reduced IRS-2
expression triggers a compensatory mechanism at least partially via
IRS-1 expression.
Previous reports suggest that IGF-1 and insulin activate Akt to
promote BAD phosphorylation and 14-3-3 binding leading to Bcl-2
activation [17,24] and inhibition of BAX-induced caspase-3 cleavage
and apoptosis in response to different stressors. The experiments of
the current study support this as a major mechanism—how IGF-1
inhibits caspase-3 activation following glucose challenge. According-
ly, we observed robustly increased BAD phosphorylation in IRS-1 and
IRS-2 overexpressing cells compared to EV and untransfected SHSY5Y
cells. Our data strongly suggest that both, IRS-1 and IRS-2, have
comparable efﬁcacy to inhibit caspase-3 activation due to glucose
neurotoxicity.
FoxO transcription factors act as downstream target of the insulin/
IGF-1 cascade which down-regulates FoxO activity via Akt mediated
phosphorylation, in turn triggering nuclear exclusion and degradation
of the FoxO transcription factors. There are four different members of
themammalian FoxO-family: FoxO1, FoxO3a, FoxO4 and FoxO6. Apart
from FoxO6, which is exclusively expressed in the brain, and FoxO4,
which has not been found in the brain [35,36], FoxO transcription
factors are found ubiquitously. Because of the shared DNA-binding
domain, FoxOs are expected to bind to similar DNA sequences [37].
Thus, all FoxOs might be able to regulate the same set of genes
through binding to this sequence. Indeed, large overlap in gene
expression is observed when comparing the transcriptional activity
during overexpression of the individual FoxOs. Functional speciﬁcity
is likely to be achieved via interaction with co-regulators [38],
suggesting that our FoxO1 mutant (DN) inhibits not only FoxO1-
mediated transcription but interferes also with the other FoxOs. Our
approach using the FoxO1DN mutant to inhibit FoxO-mediated
transcription has been successfully used in previous studies and is
well characterized [39,40]. In neurons, it has been shown that under
certain conditions Akt promotes cell survival via termination of FoxO-
mediated transcription of e.g., Fas-ligand [17]. Our experiments
revealed no effect of the FoxO1DN mutant on glucose-induced
caspase-3 activation suggesting that in the case of glucose neurotox-
icity, inhibition of FoxO-mediated transcription is not involved in the
protective effect of IRS-protein-overexpression.
The molecular mechanism of glucose-induced cellular damage is
increased oxidative stress. In the presence of hyperglycemia, glucose is
processed not only via glycolysis but also via the polyol pathway
consuming NADPH. This affects the capacity of glutathione peroxidase
to metabolize hydrogen peroxide and causes dysfunction of the
respiratory chain leading to increased free-radical levels [1,41]. In aortic
endothelial cells and in retinal cells high glucose levels lead to increased
ROS production. Overexpression of the mitochondrial MnSOD nearly
completely prevented ROS accumulation suggesting that MnSODs
antagonize glucose toxicity [9,42]. MnSOD is known to be negatively
regulated via the IR/IGF-1R signaling pathway in peripheral tissues [40].
580 O. Stöhr et al. / Biochimica et Biophysica Acta 1812 (2011) 573–580We therefore investigated MnSOD and Cu/ZnSOD in our cell lines.
Surprisingly,MnSODbutnotCu/ZnSOD is up-regulated in IRS-1 and IRS-2
overexpressing cells compared to EV and untransfected SHSY5Y cells
providing a further and newmolecular mechanism on how IRS-proteins
prevent glucose neurotoxicity. Our results suggest that MnSOD is
differently regulated in neurons compared to peripheral tissues since
IR/IGF-1R signalingvia IRS-proteins leads to increasedMnSODexpression
in our SHSY5Y cells [40].
In summary, the present study shows that both IRS-1 and IRS-2
prevent caspase-3 activation induced by hyperglycemia to similar
extent. IRS-1 and IRS-2 overexpression leads to increased BAD
phosphorylation to prevent caspase-3 cleavage reinforcing the
protective role of IGF-1R/IRS/Akt signaling in glucose neurotoxicity.
Overexpression of IRS-1 and IRS-2 increases MnSOD expression
suggesting that in contrast to peripheral tissues MnSOD is positively
regulated via the IR/IGF-1 signaling pathway in neurons providing a
new molecular mechanism of cellular protection against high glucose
levels mediated by IRS-proteins.
Supplementarymaterials related to this article can be found online
at doi:10.1016/j.bbadis.2011.02.006.
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